Literature DB >> 6972148

Four-year-old children with alpha 1-antitrypsin deficiency. Clinical follow-up and parental attitudes towards neonatal screening.

T Sveger, T Thelin.   

Abstract

Two hundred thousand infants born in Sweden between November 1972 and September 1974 were screened at birth for alpha 1-antitrypsin (alpha 1 AT) deficiency. At age 4 years 172 of 183 children with alpha 1 AT deficiency were examined and compared with 80 randomly selected control children. The children with alpha 1 AT deficiency had the following Pi types: 118 PiZ, 50 PiSZ, 2 PiZ-, 1 PiS-, 1 PiFZ. Two PiZ children have severe liver cirrhosis and 1 PiZ boy had died of aplastic anemia. Abnormal levels of serum alanine aminotransferase (S-ALAT) were found in one PiSZ and 47 PiZ children. Upper and lower respiratory infections, otitis, eczema, urinary infections or complications of child diseases did not occur more often in children with alpha 1 AT deficiency than in controls. More parents of alpha 1 AT deficient children had stopped smoking and their fathers smoked significantly less. Forty parents of children with alpha AT deficiency PiZ answered a questionnaire concerning their reaction to, knowledge about and attitudes towards neonatal screening for alpha 1 AT deficiency. Many parents reported having reacted with lack of understanding, shock or depression upon learning that the child had alpha 1 AT deficiency. About 4 years later 44% reported still lack of understanding, and 18% depression or feelings of guilt. About two-thirds had not fully understood why alpha 1 AT deficiency had been identified, despite the fact that they had seen their doctor 3--4 times for check-ups and counselling since birth.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6972148     DOI: 10.1111/j.1651-2227.1981.tb05537.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  10 in total

Review 1.  Alpha-1 antitrypsin deficiency.

Authors:  R A Primhak; M S Tanner
Journal:  Arch Dis Child       Date:  2001-07       Impact factor: 3.791

Review 2.  Ethical issues in newborn screening and the impact of new technologies.

Authors:  Bridget Wilcken
Journal:  Eur J Pediatr       Date:  2003-11-14       Impact factor: 3.183

Review 3.  alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage.

Authors:  R W Carrell
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

4.  Outcome of liver disease associated with alpha 1 antitrypsin deficiency (PiZ). Implications for genetic counselling and antenatal diagnosis.

Authors:  H T Psacharopoulos; A P Mowat; P J Cook; P A Carlile; B Portmann; C H Rodeck
Journal:  Arch Dis Child       Date:  1983-11       Impact factor: 3.791

5.  Neonatal hepatitis with obstructive jaundice in an SZ heterozygous alpha 1-antitrypsin-deficient boy and destructive lung disease in his SZ mother. A review of the literature.

Authors:  Y Vandenplas; J Franckx; I Liebaers; P Ketelbant; L Sacre
Journal:  Eur J Pediatr       Date:  1985-11       Impact factor: 3.183

6.  Hepatitis syndrome in infancy--an epidemiological survey with 10 year follow up.

Authors:  M C Dick; A P Mowat
Journal:  Arch Dis Child       Date:  1985-06       Impact factor: 3.791

7.  Alpha 1 antitrypsin deficiency due to Pi null: clinical presentation and evidence for molecular heterogeneity.

Authors:  F J Bamforth; N A Kalsheker
Journal:  J Med Genet       Date:  1988-02       Impact factor: 6.318

8.  Prenatal diagnosis of alpha 1 antitrypsin deficiency and estimates of fetal risk for disease.

Authors:  D W Cox; T Mansfield
Journal:  J Med Genet       Date:  1987-01       Impact factor: 6.318

9.  Idiopathic hemochromotosis and alpha-1-antitrypsin deficiency: coexistence in a family with progressive liver disease in the proband.

Authors:  S Anand; R R Schade; C Bendetti; R Kelly; B S Rabin; J Krause; T E Starzl; S Iwatsuki; D H Van Thiel
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

Review 10.  Diagnosis and treatment of lung disease associated with alpha one-antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand.

Authors:  Jack Dummer; Claudia C Dobler; Mark Holmes; Daniel Chambers; Ian A Yang; Lianne Parkin; Sheree Smith; Peter Wark; Anouk Dev; Sandra Hodge; Eli Dabscheck; Julian Gooi; Sameh Samuel; Steven Knowles; Anne E Holland
Journal:  Respirology       Date:  2020-02-06       Impact factor: 6.424

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.